US Stock MarketDetailed Quotes

Biodexa Pharmaceuticals (BDRX)

Watchlist
  • 3.480
  • +0.010+0.29%
Close Apr 17 16:00 ET
  • 3.542
  • +0.062+1.78%
Post 20:01 ET
2.26MMarket Cap-0.05P/E (TTM)

Biodexa Pharmaceuticals (BDRX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(FY)Dec 31, 2024
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
(FY)Dec 31, 2017
(FY)Dec 31, 2016
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
54.40%-5.59M
-79.62%-12.26M
3.15%-6.83M
-17.31%-7.05M
35.40%-6.01M
-9.3M
Net income from continuing operations
-11.43%-6.38M
19.07%-5.73M
7.54%-7.08M
-40.22%-7.66M
75.39%-5.46M
-120.02%-22.19M
32.90%-10.09M
6.44%-15.03M
20.33%-16.06M
-99.64%-20.16M
Operating gains losses
25.33%-2.4M
-561.86%-3.21M
-6.59%-485K
53.48%-455K
-275.27%-978K
--558K
----
----
----
----
Depreciation and amortization
-25.59%189K
-10.25%254K
-17.49%283K
-14.89%343K
-66.89%403K
--1.22M
----
----
----
----
Deferred tax
58.00%-105K
38.42%-250K
51.20%-406K
-28.79%-832K
49.57%-646K
28.24%-1.28M
12.16%-1.79M
-60.63%-2.03M
86.19%-1.27M
-708.47%-9.16M
Other non cash items
7,100.00%140K
95.24%-2K
-275.00%-42K
-45.45%24K
33.33%44K
-94.02%33K
-5.64%552K
334.94%585K
80.30%-249K
31.71%-1.26M
Change In working capital
145.93%1.72M
-7,524.49%-3.74M
-109.42%-49K
184.28%520K
60.40%-617K
-186.65%-1.56M
223.74%1.8M
-1.11%-1.45M
-1,087.60%-1.44M
86.42%-121K
-Change in receivables
144.00%2.63M
-1,736.99%-5.98M
5,114.29%365K
101.44%7K
-198.78%-487K
-32.00%493K
-29.61%725K
206.40%1.03M
-300.00%-968K
84.29%-242K
-Change in inventory
----
----
----
----
----
----
----
271.78%347K
14.77%-202K
-282.26%-237K
-Change in payables and accrued expense
-140.78%-913K
1,181.64%2.24M
-158.15%-207K
373.85%356K
93.51%-130K
---2M
----
----
----
----
-Change in other working capital
----
----
-231.85%-207K
--157K
----
---47K
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
54.40%-5.59M
-79.62%-12.26M
3.15%-6.83M
-17.31%-7.05M
35.40%-6.01M
-43.33%-9.3M
51.75%-6.49M
-3.84%-13.45M
1.02%-12.95M
-5.35%-13.09M
Investing cash flow
Cash flow from continuing investing activities
2.51%-583K
-125.66%-598K
-20.45%-265K
20.86%-220K
-110.80%-278K
2.57M
Net PPE purchase and sale
277.78%16K
59.09%-9K
47.62%-22K
84.89%-42K
-321.21%-278K
78.71%-66K
-41.55%-310K
69.02%-219K
47.51%-707K
-46.10%-1.35M
Net intangibles purchase and sale
9.93%-689K
-222.78%-765K
---237K
--0
--0
----
---9K
--0
-3,994.74%-778K
-533.33%-19K
Net business purchase and sale
----
----
----
----
----
----
---947K
----
----
--0
Net other investing changes
----
----
61.84%-79K
---207K
----
203.53%2.64M
-127.53%-2.55M
--9.26M
----
----
Cash from discontinued investing activities
Investing cash flow
2.51%-583K
-125.66%-598K
-20.45%-265K
20.86%-220K
-110.80%-278K
167.61%2.57M
-142.10%-3.81M
715.10%9.04M
-22.30%-1.47M
21.59%-1.2M
Financing cash flow
Cash flow from continuing financing activities
52.38%13.04M
-16.32%8.56M
21,657.45%10.23M
-99.47%47K
185.51%8.81M
3.08M
Net issuance payments of debt
-384.08%-696K
230.32%245K
-5.62%-188K
17.21%-178K
96.52%-215K
-260.20%-6.18M
166.29%3.86M
-224.25%-5.82M
2,855.88%4.69M
-3.03%-170K
Net common stock issuance
65.41%13.75M
-20.28%8.31M
4,190.95%10.43M
-97.31%243K
-7.26%9.04M
-30.95%9.74M
--14.11M
--0
--5.73M
----
Cash dividends paid
--0
--0
--0
--0
--0
--0
----
----
----
----
Net other financing activities
----
----
----
----
----
-120.11%-229K
--1.14M
----
----
----
Cash from discontinued financing activities
Financing cash flow
52.38%13.04M
-16.32%8.56M
21,657.45%10.23M
-99.47%47K
185.51%8.81M
-83.54%3.08M
389.45%18.73M
-162.98%-6.47M
-32.63%10.28M
7,065.75%15.26M
Net cash flow
Beginning cash position
-72.05%1.67M
110.54%5.97M
-71.80%2.84M
33.28%10.06M
-30.95%7.55M
366.41%10.93M
-82.26%2.34M
-25.01%13.2M
8.86%17.61M
-46.66%16.18M
Current changes in cash
259.58%6.87M
-237.22%-4.3M
143.42%3.14M
-386.66%-7.22M
169.15%2.52M
-143.18%-3.64M
177.55%8.44M
-162.42%-10.88M
-528.75%-4.15M
106.82%967K
Effect of exchange rate changes
--0
--0
--0
--0
-103.07%-8K
76.35%261K
678.95%148K
107.36%19K
-155.36%-258K
1,926.09%466K
End cash Position
411.32%8.53M
-72.05%1.67M
110.54%5.97M
-71.80%2.84M
33.28%10.06M
-30.95%7.55M
366.41%10.93M
-82.26%2.34M
-25.01%13.2M
8.86%17.61M
Free cash flow
51.81%-6.28M
-83.88%-13.04M
0.30%-7.09M
-12.36%-7.11M
33.46%-6.33M
-39.69%-9.51M
50.28%-6.81M
5.15%-13.69M
0.10%-14.44M
-8.29%-14.45M
Currency Unit
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
Unqualified Opinion
(FY)Dec 31, 2025(FY)Dec 31, 2024(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018(FY)Dec 31, 2017(FY)Dec 31, 2016
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 54.40%-5.59M-79.62%-12.26M3.15%-6.83M-17.31%-7.05M35.40%-6.01M-9.3M
Net income from continuing operations -11.43%-6.38M19.07%-5.73M7.54%-7.08M-40.22%-7.66M75.39%-5.46M-120.02%-22.19M32.90%-10.09M6.44%-15.03M20.33%-16.06M-99.64%-20.16M
Operating gains losses 25.33%-2.4M-561.86%-3.21M-6.59%-485K53.48%-455K-275.27%-978K--558K----------------
Depreciation and amortization -25.59%189K-10.25%254K-17.49%283K-14.89%343K-66.89%403K--1.22M----------------
Deferred tax 58.00%-105K38.42%-250K51.20%-406K-28.79%-832K49.57%-646K28.24%-1.28M12.16%-1.79M-60.63%-2.03M86.19%-1.27M-708.47%-9.16M
Other non cash items 7,100.00%140K95.24%-2K-275.00%-42K-45.45%24K33.33%44K-94.02%33K-5.64%552K334.94%585K80.30%-249K31.71%-1.26M
Change In working capital 145.93%1.72M-7,524.49%-3.74M-109.42%-49K184.28%520K60.40%-617K-186.65%-1.56M223.74%1.8M-1.11%-1.45M-1,087.60%-1.44M86.42%-121K
-Change in receivables 144.00%2.63M-1,736.99%-5.98M5,114.29%365K101.44%7K-198.78%-487K-32.00%493K-29.61%725K206.40%1.03M-300.00%-968K84.29%-242K
-Change in inventory ----------------------------271.78%347K14.77%-202K-282.26%-237K
-Change in payables and accrued expense -140.78%-913K1,181.64%2.24M-158.15%-207K373.85%356K93.51%-130K---2M----------------
-Change in other working capital ---------231.85%-207K--157K-------47K----------------
Cash from discontinued investing activities
Operating cash flow 54.40%-5.59M-79.62%-12.26M3.15%-6.83M-17.31%-7.05M35.40%-6.01M-43.33%-9.3M51.75%-6.49M-3.84%-13.45M1.02%-12.95M-5.35%-13.09M
Investing cash flow
Cash flow from continuing investing activities 2.51%-583K-125.66%-598K-20.45%-265K20.86%-220K-110.80%-278K2.57M
Net PPE purchase and sale 277.78%16K59.09%-9K47.62%-22K84.89%-42K-321.21%-278K78.71%-66K-41.55%-310K69.02%-219K47.51%-707K-46.10%-1.35M
Net intangibles purchase and sale 9.93%-689K-222.78%-765K---237K--0--0-------9K--0-3,994.74%-778K-533.33%-19K
Net business purchase and sale ---------------------------947K----------0
Net other investing changes --------61.84%-79K---207K----203.53%2.64M-127.53%-2.55M--9.26M--------
Cash from discontinued investing activities
Investing cash flow 2.51%-583K-125.66%-598K-20.45%-265K20.86%-220K-110.80%-278K167.61%2.57M-142.10%-3.81M715.10%9.04M-22.30%-1.47M21.59%-1.2M
Financing cash flow
Cash flow from continuing financing activities 52.38%13.04M-16.32%8.56M21,657.45%10.23M-99.47%47K185.51%8.81M3.08M
Net issuance payments of debt -384.08%-696K230.32%245K-5.62%-188K17.21%-178K96.52%-215K-260.20%-6.18M166.29%3.86M-224.25%-5.82M2,855.88%4.69M-3.03%-170K
Net common stock issuance 65.41%13.75M-20.28%8.31M4,190.95%10.43M-97.31%243K-7.26%9.04M-30.95%9.74M--14.11M--0--5.73M----
Cash dividends paid --0--0--0--0--0--0----------------
Net other financing activities ---------------------120.11%-229K--1.14M------------
Cash from discontinued financing activities
Financing cash flow 52.38%13.04M-16.32%8.56M21,657.45%10.23M-99.47%47K185.51%8.81M-83.54%3.08M389.45%18.73M-162.98%-6.47M-32.63%10.28M7,065.75%15.26M
Net cash flow
Beginning cash position -72.05%1.67M110.54%5.97M-71.80%2.84M33.28%10.06M-30.95%7.55M366.41%10.93M-82.26%2.34M-25.01%13.2M8.86%17.61M-46.66%16.18M
Current changes in cash 259.58%6.87M-237.22%-4.3M143.42%3.14M-386.66%-7.22M169.15%2.52M-143.18%-3.64M177.55%8.44M-162.42%-10.88M-528.75%-4.15M106.82%967K
Effect of exchange rate changes --0--0--0--0-103.07%-8K76.35%261K678.95%148K107.36%19K-155.36%-258K1,926.09%466K
End cash Position 411.32%8.53M-72.05%1.67M110.54%5.97M-71.80%2.84M33.28%10.06M-30.95%7.55M366.41%10.93M-82.26%2.34M-25.01%13.2M8.86%17.61M
Free cash flow 51.81%-6.28M-83.88%-13.04M0.30%-7.09M-12.36%-7.11M33.46%-6.33M-39.69%-9.51M50.28%-6.81M5.15%-13.69M0.10%-14.44M-8.29%-14.45M
Currency Unit GBPGBPGBPGBPGBPGBPGBPGBPGBPGBP
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes--Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory NotesUnqualified Opinion
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More